Industry

Medicine Advertisements Board (MAB) Guidelines And Policy

These Guidelines are intended to complement the provisions of the Medicines (Advertisement and Sale) Act 1956 (Revised 1983) and the Medicine Advertisements Board Regulations 1976.

Advertisements include any notice, circular, report, commentary, pamphlet, label, wrapper or other document, and any announcement made orally or by any means of producing or transmitting light or sound.

English

Garis Panduan Peminjaman Ubat-ubatan oleh Hospital/Klinik Perubatan Swasta dari Hospital di bawah KKM Semasa Krisis Bekalan Ubat-ubatan di Pasaran Malaysia

Garis panduan ini bertujuan untuk menguatkuasakan pemakaian Panduan Peminjaman Ubat-ubatan oleh hospital/Klinik Perubatan Swasta dari Hospital di bawah Kementerian Kesihatan Malaysia (KKM) semasa Krisis Bekalan Ubat-ubatan di Pasaran Malaysia.

Panduan ini adalah untuk rujukan mana-mana Pengamal Perubatan Swasta dari sesebuah hospital atau klinik perubatan swasta yang berdaftar di bawah Akta Kemudahan dan Perkhidmatan Jagaan Kesihatan Swasta 1998 [Akta 586] yang ingin membuat peminjaman bekalan ubat-ubatan berkaitan isu krisis bekalan ubat di pasaran Malaysia.

English

COST-BENEFIT ANALYSIS OF THE MEDICINES PRICE MECHANISM

Regulatory Impact Analysis (RIA) is a systematic process of identifying and assessing the likely impact of the proposed regulation using a consistent analytical method, such as cost-benefit analysis (CBA). RIA is a requirement by Malaysia Productivity Corporation (MPC) for any agencies intended to implement changes in the regulation.

English

Guidelines for Authors – Journal of Pharmacy Quality Improvement Initiatives (PharmQIIs)

The Journal of Pharmacy Quality Improvement Initiatives (PharmQIIs) is a peer-reviewed journal published by the Pharmaceutical Services Programme (PSP), Ministry of Health Malaysia (MOH) since 2022. PharmQIIs is set to publish manuscripts derived from Quality Improvement Initiatives (QIIs) that are conducted in Quality Improvement Reports (QIR) format.

Medicine Prices Monitoring Survey in Malaysia 2020

Medicine Prices Monitoring Survey in Malaysia / Kajian Pemantauan Harga Ubat (KPHU) is a commitment of the Pharmaceutical Services Program (PSP) to provide comprehensive information on the availability, price and affordability of medicines in Malaysia. The study conducted since 2006 requires cooperation between Malaysia's public and private healthcare sectors. The selection of facilities and medicines was based on the World Health Organization (WHO) and Health Action International (HAI) guidelines.

English

Clients' Charter Achievement 2022

CLIENTS' CHARTER ACHIEVEMENT

January - May 2022

 

Ministry of Health Medicines Formulary (MOHMF) Information Update Request Form

Any suggestion(s) to update medicine information in the MOH Medicines Formulary (MOHMF) can be submitted by completing the MOHMF Information Update Request Form which can be downloaded from this site and uploaded to

English

Clients' Charter Achievement 2021

CLIENTS' CHARTER ACHIEVEMENT

January - December 2021

 

Guidance On The Requirement To Import, Handle, Store And Distribute COVID-19 Vaccines In Malaysia

The purpose of this document is to provide guidance on the requirement to import, handle, store and distribute COVID-19 vaccines in Malaysia to ensure quality, safety dan efficacy of the products are preserved until the point of vaccina

English

Pages